Metastatic collecting duct (Bellini duct) carcinoma: A case report / 대한내과학회지
Korean Journal of Medicine
;
: 780-786, 2009.
Article
in Korean
| WPRIM
| ID: wpr-137805
ABSTRACT
Renal cell carcinoma accounts for 2.6% of all cancer, and most renal cell carcinoma has a clear cell origin. Bellini duct carcinoma, which arises from collecting duct cells (Bellini cells), is a rare type of renal cell carcinoma, constituting less than 1% of all renal cell carcinoma. The prognosis of Bellini duct carcinoma is very poor, and more than 60% of the patients die within 2 years of diagnosis. There is no consensus regarding the optimal treatment. We report a case of Bellini duct carcinoma in a 53-year-old male with multiple lung and liver metastases. The patient was treated with eight cycles of M-VAC (methotrexate, vincristine, doxorubicin, and cisplatin) combination chemotherapy. The patient currently shows a radiological partial response without disease progression 10 months after the chemotherapy.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Prognosis
/
Vincristine
/
Carcinoma, Renal Cell
/
Doxorubicin
/
Disease Progression
/
Consensus
/
Drug Therapy, Combination
/
Liver
/
Lung
/
Neoplasm Metastasis
Type of study:
Practice guideline
/
Prognostic study
Limits:
Humans
/
Male
Language:
Korean
Journal:
Korean Journal of Medicine
Year:
2009
Type:
Article
Similar
MEDLINE
...
LILACS
LIS